157 related articles for article (PubMed ID: 29801408)
1. Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cel.
Paramita P; Wardhani BW; Wanandi SI; Louisa M
Asian Pac J Cancer Prev; 2018 May; 19(5):1243-1249. PubMed ID: 29801408
[TBL] [Abstract][Full Text] [Related]
2. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
Sun XD; Liu XE; Huang DS
Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
4. Curcumin attenuates prostatic hyperplasia caused by inflammation
Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
[TBL] [Abstract][Full Text] [Related]
5. Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways.
Kumar KJ; Vani MG; Chueh PJ; Mau JL; Wang SY
PLoS One; 2015; 10(2):e0117111. PubMed ID: 25658913
[TBL] [Abstract][Full Text] [Related]
6. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
[TBL] [Abstract][Full Text] [Related]
8. Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells.
Chen WC; Lai YA; Lin YC; Ma JW; Huang LF; Yang NS; Ho CT; Kuo SC; Way TD
J Agric Food Chem; 2013 Dec; 61(48):11817-24. PubMed ID: 24236784
[TBL] [Abstract][Full Text] [Related]
9. Curcumin Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through the Inhibition of Akt/mTOR Pathway.
Zhu FQ; Chen MJ; Zhu M; Zhao RS; Qiu W; Xu X; Liu H; Zhao HW; Yu RJ; Wu XF; Zhang K; Huang H
Biol Pharm Bull; 2017 Jan; 40(1):17-24. PubMed ID: 27829579
[TBL] [Abstract][Full Text] [Related]
10. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.
Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G
World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D regulating TGF-β induced epithelial-mesenchymal transition.
Fischer KD; Agrawal DK
Respir Res; 2014 Nov; 15(1):146. PubMed ID: 25413472
[TBL] [Abstract][Full Text] [Related]
12. [In vitro study of TGF-β1-induced epithelial-mesenchymal transition of keloid epithelial cells].
Yan L; Cao R; Pan B; Wang L; Lyu X; Sun X; Xiao R
Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Mar; 31(2):128-33. PubMed ID: 26211188
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells.
Li R; Wang Y; Liu Y; Chen Q; Fu W; Wang H; Cai H; Peng W; Zhang X
PLoS One; 2013; 8(3):e58848. PubMed ID: 23544048
[TBL] [Abstract][Full Text] [Related]
14. [EGCG regulates TGF-β1-induced epithelial mesenchymal transition in squamous cell carcinoma of head and neck].
Pi LM; Liu Y; Yu CY; Cai GM; Hunag DH; Qiu YZ; Tian YQ; Zhang X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 47(9):749-52. PubMed ID: 23141445
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
Lee J; Hahm ER; Marcus AI; Singh SV
Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Targets p53-Fibrinolytic System in TGF-β1 Mediated Alveolar Epithelial Mesenchymal Transition in Alveolar Epithelial Cells.
Shaikh SB; Prabhu A; Bhandary YP
Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1441-1452. PubMed ID: 32990549
[TBL] [Abstract][Full Text] [Related]
17. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells.
Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L
Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736
[TBL] [Abstract][Full Text] [Related]
18. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial-mesenchymal transition.
Zhang C; Xu Y; Wang H; Li G; Yan H; Fei Z; Xu Y; Li W
Anticancer Drugs; 2018 Apr; 29(4):334-340. PubMed ID: 29420338
[TBL] [Abstract][Full Text] [Related]
19. Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.
Chen ZY; Wang PW; Shieh DB; Chiu KY; Liou YM
J Biomed Sci; 2015 Oct; 22():90. PubMed ID: 26482896
[TBL] [Abstract][Full Text] [Related]
20. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
Qu H; Fang L; Duan L; Long X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]